Steroids in High-Risk Pneumonia

Primary Recommendation for Severe CAP

• The American Thoracic Society explicitly recommends against routine steroid use in severe CAP, reserving hydrocortisone only for patients with refractory septic shock 1
• For patients with severe CAP and septic shock requiring vasopressors, use hydrocortisone 50 mg IV every 6 hours plus fludrocortisone 50 μg daily 1
• The 2007 IDSA/ATS guidelines support screening hypotensive, fluid-resuscitated patients with severe CAP for occult adrenal insufficiency and providing stress-dose steroids (200-300 mg hydrocortisone per day or equivalent) if inadequate cortisol response is documented 2

Evidence Quality and Nuances

• Meta-analyses demonstrate mortality benefit in severe CAP, but these studies lacked consistent definitions of disease severity, leading to a conditional (weak) recommendation against routine use 1
• The 2011 European guidelines explicitly state that steroids are NOT recommended in the treatment of pneumonia 3

Critical Contraindications

• Never use steroids in influenza pneumonia - meta-analyses show increased mortality in influenza patients receiving corticosteroids 1

Dosing Parameters When Indicated

• Do not exceed methylprednisolone 1-2 mg/kg/day equivalent 4
• Avoid high-dose steroids (hydrocortisone ≥300 mg/day or prednisolone ≥75 mg/day) as they increase hospital-acquired infections, hyperglycemia, and GI bleeding without mortality benefit 4
• Limit duration to 3-5 days to minimize infection risk and complications 4

Mandatory Monitoring and Prophylaxis

• Monitor glucose closely - hyperglycemia is the most common adverse effect requiring therapy 1
• Provide GI prophylaxis with proton pump inhibitors for all patients receiving steroids 4
• Consider Pneumocystis pneumonia prophylaxis for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks 4
• Supplement with calcium and vitamin D for prolonged steroid courses 4
• Ensure adequate fluid resuscitation before initiating steroids in septic shock 4

Common Pitfalls to Avoid

• Do not use steroids for non-severe CAP - there is no mortality benefit and a strong recommendation against routine use 1
• Watch for increased rehospitalization rates and complications in the 30-90 days following treatment 1

Steroid Use in Pneumonia

Severe Community-Acquired Pneumonia (CAP)

• The American College of Critical Care Medicine recommends using low-dose corticosteroids (hydrocortisone ≤400 mg/day equivalent) for 5-7 days in hospitalized patients with severe community-acquired pneumonia, particularly those with septic shock requiring vasopressors or elevated CRP >150 mg/L 5
• For patients with severe CAP requiring ICU admission, corticosteroids are recommended when septic shock is present and refractory to fluid resuscitation with ongoing vasopressor requirement 5
• Meta-analyses demonstrate mortality reduction specifically in severe CAP (RR 0.67, 95% CI 0.45-1.01), with benefits including reduced mechanical ventilation need (RR 0.45), prevention of ARDS (RR 0.24), and shortened hospital stay by ~3 days 5
• Consider steroids when CRP >150 mg/L at admission, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 6
• Methylprednisolone 0.5 mg/kg IV every 12 hours for 5 days or Prednisone 50 mg daily orally for those able to take oral medication can be used for severe CAP without shock but with high inflammatory markers, as suggested by the Pharmacology and Therapeutics society 6

Non-Severe CAP

• The European Society of Clinical Microbiology and Infectious Diseases explicitly states that steroids are NOT recommended in pneumonia treatment for mild-to-moderate CAP requiring hospitalization but not ICU care 7, 8
• The IDSA/ATS guidelines give a strong conditional recommendation AGAINST routine steroid use in CAP, citing no mortality benefit and increased risk of hyperglycemia, GI bleeding, and secondary infections 6

Critical Contraindications

• The American College of Critical Care Medicine and the European Society of Clinical Microbiology and Infectious Diseases recommend NEVER using steroids in influenza pneumonia, as meta-analyses consistently demonstrate increased mortality with corticosteroid use in influenza patients 5, 6

Mandatory Monitoring and Prophylaxis

• Monitor glucose closely, as hyperglycemia is the most common adverse effect requiring intervention, as recommended by the American College of Critical Care Medicine 5

Corticosteroid Use in Healthcare‑Associated Pneumonia (HCAP)

Routine Use Recommendation

• The ATS/IDSA 2005 and 2016 HAP/VAP/HCAP guidelines strongly recommend against routine adjunctive corticosteroids for HCAP, reserving steroids only for cases of refractory septic shock requiring vasopressor support. 9, 10

Indications for Steroid Use

• Corticosteroids should be used exclusively in HCAP patients who develop refractory septic shock (persistent hypotension despite adequate fluid resuscitation and need for vasopressors). 10

Risks Specific to HCAP

• HCAP patients exhibit higher rates of multidrug‑resistant organisms compared with community‑acquired pneumonia, increasing the potential for adverse outcomes if steroids are added. 9, 10
• These patients often have greater immunosuppression from comorbid conditions, further elevating infection risk. 9
• The baseline risk of infection in HCAP is already elevated, and corticosteroid therapy could worsen this risk. 10

Guideline Updates and Recommendations

• The 2019 ATS/IDSA CAP guideline eliminated the HCAP categorization, recommending that treatment decisions be based on local epidemiology and validated risk factors for MRSA/Pseudomonas rather than the historic HCAP label. 11

Clinical Pitfalls

• Do not extrapolate steroid efficacy data from CAP trials to HCAP, because the patient populations and pathogen spectra differ fundamentally. 9, 10, 11
• Steroids are not indicated for non‑severe HCAP; there is no demonstrated mortality benefit and a strong recommendation against routine use. 11